13F-HR 1 w05713be13fvhr.txt FORM 13F UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 13F Form 13F COVER PAGE Report for Calendar Year or Quarter Ended: December 31, 2004 Check here if Amendment [ ]; Amendment Number: This Amendment (Check only one.): [ ] is a restatement. [ ] adds new holdings entries. Institutional Investment Manager Filing this Report: Name: BB Biotech AG Address: Vordergasse 3 Schaffhausen Switzerland CH-8200 Form 13F File Number: 28-6964 The institutional investment manager filing this report and the person by whom it is signed hereby represent that the person signing the report is authorized to submit it, that all information contained herein is true, correct and complete, and that it is understood that all required items, statements, schedules, lists, and tables are considered integral parts of this form. Person Signing this Report on Behalf of Reporting Manager: Name: Adrian Bruengger Title: SIGNING AUTHORITY ----------------- Phone: 41 (01) 267 67 00 Signature, Place, and Date of Signing: /s/ Adrian Bruengger ------------------------------------------ Schaffhausen, Switzerland, February 10, 2005 Report Type (Check only one.): [X] 13F HOLDINGS REPORT. (Check here if all holdings of this reporting manager are reported in this report.) [ ] 13F NOTICE. (Check here if no holdings reported are in this report, and all holdings are reported by other reporting manager(s).) [ ] 13F COMBINATION REPORT. (Check here if a portion of the holdings for this reporting manager are reported in this report and a portion are reported by other reporting manager(s).) Form 13F SUMMARY PAGE Report Summary: Number of Other Included Managers: 4 Form 13F Information Table Entry Total: 17 Form 13F Information Table Value Total: $1,414,738 (thousands) List of Other Included Managers: Provide a numbered list of the name(s) and Form 13F file number(s) of all institutional investment managers with respect to which this report is filed, other than the manager filing this report.
No. Name 1 Biotech Focus N.V. 2 Biotech Invest N.V. 3 Biotech Target N.V. 4 Biotech Growth N.V.
BB BIOTECH AG FORM 13F INFORMATION TABLE
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8 ---------------------------- -------- --------- -------- -------------------- ---------- -------- ----------------------- TITLE OF VALUE SHS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY NAME OF ISSUER CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGERS SOLE SHARED NONE ---------------------------- -------- --------- -------- --------- --- ---- ---------- -------- --------- ------ ---- Amgen Inc. COM 031162100 64,150 1,000,000 SH DEFINED 1 1,000,000 NONE NONE Auxilium Pharmaceuticals, Inc. COM 05334D107 8,850 1,000,000 SH DEFINED 4 1,000,000 NONE NONE Biogen Idec Inc. COM 09062X103 145,271 2,180,913 SH DEFINED 1 2,180,913 NONE NONE Celgene Corporation COM 151020104 135,077 5,093,400 SH DEFINED 2 5,093,400 NONE NONE Elan Corporation, plc COM 284131208 54,500 2,000,000 SH DEFINED 2 2,000,000 NONE NONE EyeTech Pharmaceuticals, Inc. COM 302297106 186,923 4,108,194 SH DEFINED 4 4,108,194 NONE NONE Genzyme Corporation COM 372917104 129,438 2,229,000 SH DEFINED 1 2,229,000 NONE NONE Gilead Sciences, Inc. COM 375558103 209,940 6,000,000 SH DEFINED 1 6,000,000 NONE NONE ICOS Corporation COM 449295104 29,578 1,045,900 SH DEFINED 3 1,045,900 NONE NONE Idenix Pharmaceuticals, Inc. COM 45166R204 7,409 432,008 SH DEFINED 3 432,008 NONE NONE Incyte Corporation COM 45337C102 27,972 2,800,000 SH DEFINED 3 2,800,000 NONE NONE Ligand Pharmaceuticals Incorporated COM 53220K207 56,687 4,870,000 SH DEFINED 2 4,870,000 NONE NONE Pozen Inc. COM 73941U102 9,799 1,347,800 SH DEFINED 3 1,347,800 NONE NONE Sepracor Inc. COM 817315104 178,110 3,000,000 SH DEFINED 1 3,000,000 NONE NONE The Medicines Company COM 584688105 119,129 4,136,419 SH DEFINED 3,4 4,136,419 NONE NONE Theravance, Inc. COM 88338T104 35,928 2,007,168 SH DEFINED 4 2,007,168 NONE NONE Virologic, Inc. COM 92823R201 15,977 5,726,430 SH DEFINED 3,4 5,726,430 NONE NONE